SECTION 9.3: EXPANDED ACCESS / …
nhs greater glasgow and clyde policies relating to the management of medicines section 9: unlicensed medicines document produced by: j. …
Download SECTION 9.3: EXPANDED ACCESS / …
Information
Domain:
Source:
Link to this page:
Documents from same domain
DRUG INDUCED QT PROLONGATION - GGC …
www.ggcprescribing.org.ukIssue 21, December 2012 Produced by NHS Greater Glasgow and Clyde Medicines Information Service . DRUG INDUCED QT PROLONGATION Prolongation of the QT interval can lead to a
Safe and Secure Handling of Medicines in Hospital …
www.ggcprescribing.org.ukSafe and Secure Handling of Medicines in Hospitals Wards, Theatres and Departments i Safe and Secure Handling of Medicines in Hospital Wards, Theatres and Departments
NOAC Prescribing in Patients with Non-Valvular …
www.ggcprescribing.org.ukThis document supersedes previous document entitled “Guidance on Anticoagulant Choice in Patients with Non-Valvular Atrial Fibrillation, Version 2 August 2014”
CLOPIDOGREL & POSSIBLE INTERACTION …
www.ggcprescribing.org.ukstatement re-iterating their alert sent to healthcare professionals in November 2009 advising against concurrent use of clopidogrel and omeprazole. 6,7 The interaction between clopidogrel and PPIs has been
1. Drug Interactions - GGC Prescribing
www.ggcprescribing.org.ukIssue 11, June 2013 Produced by NHS Greater Glasgow and Clyde Medicines Information Service and PPSU Clinical Governance Team . In this issue:
SECTION 9.2: UNLICENSED MEDICINES POLICY – …
www.ggcprescribing.org.uknhs greater glasgow and clyde policies relating to the management of medicines section 9: unlicensed medicines policy document produced by: unlicensed medicines short-life working group date of last revision: january 2010
Prescribing advice on animal derived medicines in within ...
www.ggcprescribing.org.ukPurpose of document For Prescribers and Prescribing Advisors who are approached by patients who wish to avoid animal products for religious, cultural or ethical reasons or those who are
Related documents
First in Human Studies - ABPI
www.abpi.org.ukFirst in Human Studies: Points to Consider in Study Placement, Design and Conduct January 2011
E 11 Clinical Investigation of Medicinal Products in …
www.ema.europa.euEuropean Medicines Agency 7 Westferry Circus, Canary Wharf, London, E14 4HB, UK Tel. (44-20) 74 18 85 75 Fax (44-20) 75 23 70 40 E-mail: mail@emea.eu.int http://www.emea.eu.int
E17 Step 5 on general principles for planning and …
www.ema.europa.eu30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema ...
Technology Solutions Monitoring Adverse Events in …
www.imsbrogancapabilities.comMonitoring Adverse Events in Pharma’s Patient Support Programs Page 3 The need for engagement The value of patient engagement to pharma cannot be overstated.
2013 No. 1198 REHABILITATION OF OFFENDERS, …
www.legislation.gov.ukSTATUTORY INSTRUMENTS 2013 No. 1198 REHABILITATION OF OFFENDERS, ENGLAND AND WALES The Rehabilitation of Offenders Act 1974 (Exceptions) Order